["{\n\"step_by_step_thinking\": \"The question is about the combination of a certain substance with chemotherapies in the treatment of human ovarian cancer. The provided documents are related to ovarian cancer treatment, including the use of cisplatin-based chemotherapy and the study on lonidamine's enhancement of cisplatin activity. However, there is no mention of 2-methoxyestradiol or its combination with chemotherapies in these documents. Therefore, it is not possible to draw a conclusion based on the provided information.\",\n\"answer_choice\": \"B\"\n}"]